Tyndall Capital Partners’s Onconova Therapeutics, Inc. Warrants ONTXW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-390,624
| Closed | -$14K | – | 2 |
|
|
2019
Q4 | $14K | Hold |
390,624
| – | – | 0.6% | 2 |
|
|
2019
Q3 | $8K | Hold |
390,624
| – | – | 0.3% | 3 |
|
|
2019
Q2 | $70K | Hold |
390,624
| – | – | 1.42% | 3 |
|
|
2019
Q1 | $74K | Hold |
390,624
| – | – | 1.46% | 3 |
|
|
2018
Q4 | $16K | Hold |
390,624
| – | – | 0.45% | 3 |
|
|
2018
Q3 | $39K | Hold |
390,624
| – | – | 0.49% | 3 |
|
|
2018
Q2 | $5K | Hold |
390,624
| – | – | 0.07% | 3 |
|
|
2018
Q1 | $117K | Hold |
390,624
| – | – | 3.05% | 3 |
|
|
2017
Q4 | $215K | Hold |
390,624
| – | – | 6.19% | 3 |
|
|
2017
Q3 | $152K | Hold |
390,624
| – | – | 1.94% | 4 |
|
|
2017
Q2 | $176K | Hold |
390,624
| – | – | 2.08% | 4 |
|
|
2017
Q1 | $327K | Hold |
390,624
| – | – | 9.4% | 3 |
|
|
2016
Q4 | $391K | Hold |
390,624
| – | – | 13.7% | 3 |
|
|
2016
Q3 | $391K | Buy |
+390,624
| New | +$391K | 21.2% | 2 |
|